Results of Extraordinary General Meeting
Released
Released
Announcement PDF
Results of Extraordinary General Meeting
MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 12 April 2024 Alterity Therapeutics (ASX:
ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) advises that all resolutions considered at the
Extraordinary General Meeting held today were carried by poll.
In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of
the proxies received and votes cast in respect of each resolution are attached.
Phillip Hains
Company Secretary
Alterity Therapeutics Limited ACN 080 699 065
Level 3, 62 Lygon Street Carlton Victoria 3053 Australia
www.alteritytherapeutics.com
Share your feedback
Discover